Back to Trials
NCT06682429NARecruiting

Telerehabilitation In The Home After Stroke

University of California, Los Angeles

Start Date

8/22/2025

Completion Date

6/1/2030

Summary

The purpose of this research study is to evaluate whether telerehabilitation targeting arm movement, when added to usual care, improves arm function and reduces global disability after stroke, compared to usual care alone. Patients with arm weakness due to stroke that happened in the past 90-150 days will be randomized into one of two groups: \[1\] TR and usual care; \[2\] usual care only (no TR), but people in the usual care group will be offered TR once the study is done. TR consists of 70 minutes/day of activities targeting arm function, 6 days a week for 6 weeks.

Detailed Description

This is a randomized, assessor-blinded study that involves the use of telerehabilitation to deliver additional therapy for persons with stroke. Patients with arm weakness due to stroke that happened in the past 90-150 days will be randomized into one of two groups: \[1\] TR and usual care; \[2\] usual care only (no TR), but people in the usual care group will be offered TR once the study is done. TR consists of 70 minutes/day of activities targeting arm function, 6 days a week 6-8 weeks. The hypothesis of this study is patients receiving TR in addition to their usual care will have significantly greater recovery of arm function compared to patients receiving usual care alone. Study participation will last approximately 8 months and includes 4 in-person visits. At these visits, patients will undergo a variety of assessments including tests of arm function and a single MRI scan of the brain. Patients undergoing TR will receive arm motor training, which consists of 36 sessions of assigned exercises, games, and stroke education; these total 70 minutes in length and occur 6 days a week for 6 weeks; TR subjects will also continue usual care. Patients in the usual care group only will not engage in TR but will instead continue all of the therapies recommended by their medical team. At the end of the study, participants in the usual care group will be offered TR.

Eligibility Criteria

Age Range: 18 years to 80 years

Inclusion Criteria: 1. Age 18-80 years at the time of randomization 2. The index stroke was radiologically verified, due to ischemia or intracerebral hemorrhage (ICH), and had time of onset 120±30 days prior to randomization 3. The stroke caused upper extremity deficits as defined by Action Research Arm Test score 18-44 (out of 57) at Baseline Visit 1 4. Box \& Block Test score with affected arm is ≥1 block in 60 seconds at Baseline Visit 1 5. Able to successfully perform all 3 rehabilitation exercise test examples (simple commands) at Baseline Visit 1 6. Informed consent and behavioral contract signed by the subject (i.e., no surrogate consent) Exclusion Criteria: 1. A major, active, coexistent neurological, psychiatric, or medical disease that reduces the likelihood that a subject will be able to comply with all study procedures 2. Unable or unwilling to perform study procedures/therapy, or expectation of noncompliance with study procedures/therapy, or expectation that subject cannot participate in all study visits 3. A diagnosis (apart from the index stroke) that substantially affects paretic arm function 4. Severe depression, defined as Geriatric Depression Scale Score \>10/15 at Baseline Visit 1 5. Significant cognitive impairment, defined as Montreal Cognitive Assessment score \<22 \[a lower score is permitted if due to aphasia and allowed by the site PI\] 6. Deficits in communication that interfere with reasonable study participation 7. Severe UE spasticity, defined as presence of contracture or modified Ashworth Scale score=4 in either biceps or pectoralis 8. Modified Rankin Scale score was \>2 prior to the index stroke 9. A new symptomatic stroke has occurred since the index stroke, or a separate stroke occurred within 30 days prior to the index stroke 10. Lacking visual acuity, with or without corrective lens, of 20/50 or better in at least one eye 11. Life expectancy \< 9 months 12. Pregnant; women of child-bearing potential must have a negative pregnancy test 13. Botulinum toxin to the paretic arm: received in the prior 3 months OR expected by the 8-Month Visit 14. Concurrent enrollment in another therapy-based investigational study where the duration of the investigational therapy's activity is likely to occur during the subject's participation in the study 15. Subject lacks sufficient English or Spanish to comply with study procedures and TR instructions 16. Expectation that subject will not have a single domicile address during the 6 weeks of therapy that is within 1.5-hr drive of the central study site \[this can be waived at the discretion of the site PI\] 17. Contraindication to MRI 18. On isolation precautions, e.g., due to active COVID-19

Interventions

DEVICE

Telerehabilitation

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Stroke

Locations

Rancho Los Amigos Research Institute

Downey, California 90242

United States

University of California, Irvine

Irvine, California 92868

United States

Keck Medical Center of USC

Los Angeles, California 90033

United States

University of California, Los Angeles

Los Angeles, California 90095

United States

Casa Colina Hospital and Centers for Healthcare

Pomona, California 91767

United States

Hillcrest Medical Center at UC San Diego Health

San Diego, California 92103

United States

Medstar Health Research Institute

Washington D.C., District of Columbia 20010

United States

Brooks Rehabilitation Hospital

Jacksonville, Florida 32216

United States

Jackson Memorial Hospital Christine E. Lynn Rehabilitation Center

Miami, Florida 33136

United States

Emory Rehabilitation Hospital

Atlanta, Georgia 30322

United States

University of Kansas Medical Center

Kansas City, Kansas 66160

United States

Massachusetts General Hospital

Boston, Massachusetts 02114

United States

Spaulding Rehabilitation Hospital

Charlestown, Massachusetts 02129

United States

Baystate Medical Center

Springfield, Massachusetts 01199

United States

University of Michigan University Hospital

Ann Arbor, Michigan 48108

United States

Icahn School of Medicine at Mount Sinai

New York, New York 10029

United States

NYP Columbia University Medical Center

New York, New York 10032

United States

University of North Carolina Medical Center

Chapel Hill, North Carolina 27514

United States

Duke University Hospital

Durham, North Carolina 27710

United States

University of Cincinnati

Cincinnati, Ohio 45219

United States

MetroHealth Old Brooklyn Health Center

Cleveland, Ohio 44109

United States

Cleveland Clinic Foundation

Cleveland, Ohio 44195

United States

Jefferson Moss Rehabilitation Research Institute

Elkins Park, Pennsylvania 19027

United States

Medical University of South Carolina

Charleston, South Carolina 29425

United States

The Institute for Rehabilitation and Research (TIRR) Memorial Hermann

Houston, Texas 77030

United States

UT Houston/Memorial Hermann Hospital TMC

Houston, Texas 77030

United States

University of Utah Health

Salt Lake City, Utah 84132

United States